Aspo Plc
11.12.2025 17:30:00 CET | Globenewswire | Press release
Aspo Plc: Share repurchase 11.12.2025
Aspo Plc: Share repurchase 11.12.2025
| Aspo Plc | ANNOUNCEMENT | 11.12.2025 |
| Aspo Plc: Share repurchase 11.12.2025 | ||
| In the Helsinki Stock Exchange | ||
| Trade date | 11.12.2025 | |
| Bourse trade | Buy | |
| Share | ASPO | |
| Amount | 2 906 | Shares |
| Average price/ share | 6,6330 | EUR |
| Total cost | 19 275,50 | EUR |
| Aspo Plc now holds a total of 83 461 shares | ||
| including the shares repurchased on 11.12.2025 | ||
| The share buybacks are executed in compliance with Regulation | ||
| No. 596/2014 of the European Parliament and Council (MAR) Article 5 | ||
| and the Commission Delegated Regulation (EU) 2016/1052. | ||
| On behalf of Aspo Plc | ||
| Nordea Bank Oyj | ||
| Sami Huttunen | Ilari Isomäki | |
| For more information, please contact: | ||
| Erkka Repo, CFO, Aspo Plc, tel. +358 40 5827 971, erkka.repo@aspo.com | ||
| www.aspo.com | ||
Attachment
Documents
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Northland Power Inc.13.8.2026 00:55:55 CEST | Press release
Northland Power Reports Second Quarter 2026 Results and Construction Progress Updates
Energy Metal News12.8.2026 22:07:23 CEST | Press release
Skaergaard’s 2026 Resource Used a $3,500 Gold Assumption; Gold Has Since Traded Above $4,300
Zealand Pharma12.8.2026 22:05:00 CEST | Press release
Zealand Pharma enters into a USD 100 million royalty purchase and sale agreement with Royalty Pharma for the economics related to rusfertide
Kvika banki hf.12.8.2026 17:35:00 CEST | Press release
Kvika banki hf.: Financial Results for Q2 2026
Inter-American Development Bank12.8.2026 17:30:00 CEST | Press release
IDB Group’s Amazonia for All Initiative Has First ETF with BTG Pactual Asset
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom